We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00377065
Recruitment Status : Approved for marketing
First Posted : September 15, 2006
Last Update Posted : April 22, 2016
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Approved for marketing
  Primary Completion Date : No date given
  Study Completion Date : No date given